Findings of Gynecomastia That Developed in Follow-up Secondary to Bicalutamide Treatment on Bone Scan

Kemal Ünal1, Nahide Gökçora2

  • 1Acıbadem University, Department of Nuclear Medicine, İstanbul, Turkey.

Insights

Bicalutamide, a prostate cancer drug, can cause painful gynecomastia (breast enlargement) as a side effect. Bone scans may reveal this condition, necessitating physical examination for accurate diagnosis.

Area of Science:

  • Oncology
  • Endocrinology

Background:

  • Prostate cancer is a prevalent neoplastic disease, particularly in elderly males.
  • Metastatic prostate cancer is associated with a poor five-year survival rate.
  • Bicalutamide is an androgen receptor antagonist used in prostate cancer treatment.

Purpose of the Study:

  • To report a case of bilateral painful gynecomastia in a patient undergoing prostate cancer treatment.
  • To highlight the potential of bone scan blood pool imaging in detecting Bicalutamide-induced gynecomastia.
  • To emphasize the importance of correlating imaging findings with physical examination.

Main Methods:

  • A 79-year-old male with prostate cancer underwent a bone scan.
  • Blood pool images from the bone scan were analyzed for changes in breast vascularity.
  • Physical examination was performed to assess for gynecomastia.

Main Results:

  • Bone scan blood pool images revealed bilateral hyperemia in the breast regions, a new finding compared to a previous scan.
  • Physical examination confirmed bilateral painful gynecomastia.
  • The patient was receiving Bicalutamide therapy for prostate cancer.

Conclusions:

  • Bilateral hyperemia on bone scan blood pool images may indicate Bicalutamide-induced gynecomastia.
  • Clinical evaluation, including physical examination, is crucial when imaging suggests gynecomastia.
  • Early detection of this side effect can aid in patient management.

Related Concept Videos